arrow
A

Ashwin Somasundaram

pennsylvania commonwealth system of higher education (pcshe)
H指数:18
被引数:1,583

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MET alterations are enriched in lung adenocarcinoma brain metastases, defining a distinct biologic subtype

MET基因突变在肺腺癌脑转移中富集,定义了一种独特的生物学亚型

2026-02-160
OA
Phase II single-arm study of palbociclib and cetuximab in anti-EGFR naïve patients with KRAS/NRAS/BRAF wild-type, metastatic colorectal cancer

II期单臂研究,评估帕博西利和西妥昔单抗在抗EGFR初治、KRAS/NRAS/BRAF野生型、转移性结直肠癌患者中的疗效。

2025-10-010
OAAI
Dysfunctional CD11c-CD21- extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer

功能障碍性CD11c⁻CD21⁻生发中心外记忆B细胞在癌症患者的周围组织和肿瘤中富集

2025-02-190
PRE
An open label, phase II trial of ERK inhibition alone and in combination with autophagy inhibition in patients with metastatic cancreatic cancer
2024-09-150
PRE
Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19
2022-06-0112
OAAI
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer

肿瘤内调节性T细胞表达neuropilin-1的患病率与癌症患者预后较差相关

2021-12-0826
OA
People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden
2021-12-0113
OAAI
COVID-19 versus Non-COVID-19 Acute Respiratory Distress Syndrome Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes
2021-07-01113
OAAI
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study

在嵌合抗原受体修饰的T细胞治疗接受者中,顽固性冠状病毒疾病2019 (新型冠状病毒肺炎) 和新型冠状病毒冠状病毒2 (SARS-CoV-2) 复制延长: 案例研究

2021-01-28109
OAAI